Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1168-1173

  Levy, David A ^a   Swanson, David A ^a,b   Slaton, Joel W ^a   Ellerhorst, Julie ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinoma; Kidney; Neoplasm metastasis; Nephrectomy; Renal cell

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031944335     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63542-0     Document Type: Article

References (27)

1. Rosenberg, S. A., Lotze, M. T., Yang, Y. C., Linehan, W. M., Seipp, C., Calabro, S., Karp, S. E., Sherry, R. M., Steinberg, S. and White, D. E.: Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J. Clin. Oncol., 7: 1863, 1989.
2. Hrushesky, W. J., von Roemeling, R., Lanning, R. M. and Rabatin, J. T.: Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. J. Clin. Oncol., 8: 1504, 1990.
3. Muss, H. B.: Interferon therapy for renal cell carcinoma. Sem. Oncol., 14: 36, 1987.
4. Sella, A., Logothetis, C. J., Fitz, K., Dexeus, F. H., Amato, R., Kilbourn, R. and Wallace, S.: Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. J. Urol., 147: 573, 1992.
5. Sella, A., Logothetis, C. J., Fitz, K., Dexeus, F. H., Amato, R., Kilbourn, R. and Wallace, S.: Recombinant interferon alpha (Roferon) combined with 5-fluorouracil based chemotherapy in metastatic renal cell cancer. J. Urol., part 2, 145: 273A, abstract 241, 1991.
6. Franklin, J. R., Figlin, R., Rauch, J., Gitlitz, B. and Belldegrun, A.: Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience. Sem. Urol. Oncol., 14: 230, 1996.
7. Walther, M. M., Alexander, R. B., Weiss, G. H., Venzon, D., Berman, A., Pass, H. I., Linehan, W. M. and Rosenberg, S. A.: Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology, 42: 250, 1993.
8. Bennett, R. T., Lerner, S. E., Taub, H. C., Dutcher, J. P. and Fleischman, J.: Cytoreductive surgery for stage IV renal cell carcinoma. J. Urol., 154: 32, 1995.
9. Johnson, D. E., Kaesler, K. E. and Samuels, M. L.: Is nephrectomy justified in patients with metastatic renal carcinoma? J. Urol., 114: 27, 1975.
10. Skinner, D. B., Colvin, R. B., Vermillion, C. D., Pfister, R. C. and Leadbetter, W. F.: Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 28: 1165, 1971.
11. Naito, S., Kimiya, K., Sakamoto, N., Soejima, T., Ueda, T., Kumazawa, J., Osada, Y., Kurozumi, T., Sagiyama, K. and Ariyoshi, A.: Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma. Urology, 37: 95, 1991.
12. Beahrs, O. H., Henson, D. E., Hutter, R. V. P. and Kennedy, B. J.: In: American Joint Committee on Cancer Manual for Staging of Cancer, 4th ed. Philadelphia: J. B. Lippincott Co., 1992.
13. O'dea, M. J., Zincke, H., Utz, D. C. and Bernatz, P. E.: The treatment of renal cell carcinoma with solitary metastasis. J. Urol., 120: 540, 1978.
14. Cerfolio, R. J., Allen, M. S., Deschamps, C., Daly, R. C., Wallrich, S. L., Trastek, V. F. and Pairolero, P. C.: Pulmonary resection of metastatic renal cell carcinoma. Ann. Thor. Surg., 57: 339, 1994.
15. Pongracz, N., Zimmerman, R. and Kotz, R.: Orthopaedic management of bony metastases of renal cancer. Semin. Surg. Oncol., 4: 139, 1988.
16. Skipper, H. E. and Schabel, F. M.: Quantitative and cytokinetic studies in experimental tumor models. In: Cancer Medicine. Edited by J. F. Holland and E. Frei, III. Philadelphia: Lea & Febiger, pp. 629-650, 1973.
17. Whitney, R. B., Levy, J. G. and Smith, A. G.: Influence of tumor size and surgical resection on cell-mediated immunity in mice. J. Natl. Cancer Inst., 53: 111, 1974.
18. Montie, J. E., Straffon, R. A., Deodhar, S. D. and Barna, B.: In vitro assessment of cell mediated immunity in patients with renal cell carcinoma. J. Urol., 115: 239, 1976.
19. Le Francois, D., Youn, J. K., Belehradek, J., Jr. and Barski, G.: Evolution of cell mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells. J. Natl. Cancer Inst., 46: 981, 1971.
20. Robertson, C. N., Linehan, W. M., Pass, H. I., Gomella, L. G., Hass, G. P., Berman, A., Merino, M. and Rosenberg, S. A.: Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. J. Urol., 144: 614, 1990.
21. Fisher, R. I., Coltman, C. A., Jr., Doroshow, J. H., Rayner, A. A., Hawkins, M. J., Mier, J. W., Wiernik, P., McMannis, J. D., Weiss, G. R., Margolin, K. A., Gemlo, B., Hoth, D., Parkinson, D. and Paietta, E.: Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. Ann. Intern. Med., 108: 518, 1988.
22. Levine, E.: Malignant renal parenchymal tumors in adults. In: Clinical Urography: An Atlas and Textbook of Urological Imaging. Edited by H. M. Pollack. Philadelphia: W. B. Saunders Co., pp. 1216-1291, 1990.
23. Levine, E., Lee, K. R. and Weigel, J.: Preoperative determination of abdominal extent of renal cell carcinoma by computed tomography. Radiology, 132: 395, 1979.
24. Studer, U. E., Scherz, S., Scheidegger, J., Kraft, R., Sonntag, R., Ackerman, D. and Zingg, E. J.: Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J. Urol., 144: 243, 1990.
25. Rackley, R., Novick, A., Klein, E., Bukowski, R., McLain, D. and Goldfarb, D.: The impact of adjuvant nephrectomy on multi-modality treatment of metastatic renal cell carcinoma. J. Urol., 152: 1399, 1994.
26. Wolf, J. S., Aronson, F. R., Small, E. J. and Carroll, P. R.: Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens. J. Surg. Oncol., 55: 7, 1994.
27. Swanson, D., Markowitz, A., Wishnow, K., von Eschenbach, A., Quesada, J. and Logothetis, C.: Primary biologic therapy with delayed radical nephrectomy for patients with metastatic renal cell carcinoma. J. Urol., part 2, 143: 293A, abstract 419, 1990.